Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy

American Journal of Roentgenology

Volumn 188, Issue 6, 2007, Pages 1513-1520

  Fayad, Laura M ^a   Barker, Peter B ^a   Jacobs, Michael A ^a   Eng, John ^a   Weber, Kristin L ^a   Kulesza, Piotr ^b   Bluemke, David A ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Bone; MR spectroscopy; MR technique; MRI; Oncologic imaging; Soft tissue neoplasms

Indexed keywords

CHOLINE; GADOLINIUM PENTETATE MEGLUMINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE CYST; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HEMANGIOMA; HISTOPATHOLOGY; HUMAN; LIPOMA; MALE; MEASUREMENT; METASTASIS; MUSCULOSKELETAL DISEASE; MYOCUTANEOUS FLAP; NEUROFIBROMA; POPLITEAL CYST; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SARCOMA; SIGNAL NOISE RATIO; STRESS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE NEOPLASMS; CHOLINE; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE NEOPLASMS; NEOPLASMS, CONNECTIVE TISSUE; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34249895305     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.06.0935     Document Type: Article

References (19)

1. Berquist TH, Ehman RL, King BF, Hodgman CG, Ilstrup DM. Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions. AJR 1990; 155:1251-1255
2. Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 1992; 185:581-586
3. May DA, Good RB, Smith DK, Parsons TW. MR imaging of musculoskeletal tumors and tumor mimickers with intravenous gadolinium: experience with 242 patients. Skeletal Radiol 1997; 26:2-15
4. Oya N, Aoki J, Shinozaki T, Watanabe H, Takagishi K, Endo K. Preliminary study of proton magnetic resonance spectroscopy in bone and soft-tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor. Radiat Med 2000; 18:193-198
5. 1H MR spectroscopy: initial results. Radiology 2004; 232:599-605
6. Fayad LM, Bluemke DA, McCarthy EF, Weber KL, Barker PB, Jacobs MA. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging 2006; 23:23-28
7. Gonen O, Gruber S, Li BS, Mlynarik V, Moser E. Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. Am J Neuroradiol 2001; 22:1727-1731
8. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 1997; 37:222-225
9. Inglese M, Spindler M, Babb JS, Sunenshine P, Law M, Gonen O. Field, coil, and echo-time influence on sensitivity and reproducibility of brain proton MR spectroscopy. Am J Neuroradiol 2006; 27:684-688
10. Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 2001; 45:765-769
11. 1H-spectroscopic imaging of the prostate. Invest Radiol 2004; 39:671-680
12. Fischbach F, Thormann M, Ricke J. (1)H magnetic resonance spectroscopy (MRS) of the liver and hepatic malignant tumors at 3.0 Tesla [in German]. Radiologe 2004; 44:1192-1196
13. Li CW, Kuo YC, Chen CY, et al. Quantification of choline compounds in human hepatic tumors by proton MR spectroscopy at 3 T. Magn Reson Med 2005; 53:770-776
14. 1H-MR spectroscopic imaging of the human prostate at 3T. Magn Reson Med 2005; 53:1268-1274
15. Sosna J, Pedrosa I, Dewolf WC, Mahallati H, Lenkinski RE, Rofsky NM. MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. Acad Radiol 2004; 11:857-862
16. Bloch BN, Rofsky NM, Baroni RH, Maquis RP, Pedrosa I, Lenkinski RE. 3-Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils: initial experience(1). Acad Radiol 2004; 11:863-867
17. Katz-Brull R, Rofsky NM, Lenkinski RE. Breath-hold abdominal and thoracic proton MR spectroscopy at 3T. Magn Resan Med 2003; 50:461-467
18. Schellinger D, Lin CS, Hatipoglu HG, Fertikh D. Potential value of vertebral proton MR spectroscopy in determining bone weakness. Am J Neuroradiol 2001; 22:1620-1627
19. 1H magnetic resonance spectroscopy of brain metastases at 1.5T and 3T. Acta Radiol 2006; 47:501-508